We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
A new world is possible. Let's not go back to what wasn't working anyway.
Add this topic to your myFT Digest for news straight to your inbox
Many of the same advisers collected hefty fees when AT&T bought company five years ago
Advisers profit while conglomerate’s market value has slumped about 75% since 2000
Panera secures investment from restaurateur Danny Meyer and his Union Square Hospitality Group Spac
Pharmaceutical group raises record debt with social and environmental strings attached
Personalised cancer treatments are among those being developed using a technology once distrusted by big pharma
Ugur Sahin says the virus is very likely to mutate and evade immunity given by current jabs
Americans are perplexed by weeks of conflicting messages and differing state guidelines
Acute shortage of staff forces hospitals in worst-affected states to ration patient care
Scientists seek breakthrough in effort to ease virus symptoms and speed up recovery times
Elderly and at-risk to be offered third dose of BioNTech/Pfizer Covid-19 jab under scaled-back plan
Agency decision to restrict third jabs to vulnerable Americans deals blow to Biden’s strategy
Advisory committee endorses third dose only for elderly and at-risk groups in blow to Biden
Analysts predict revenues from Covid-19 jabs will fall precipitously by 2024
Data come as US regulator weighs approval for booster shot to bolster immunity
Executive signals intention to secure authorisation for infants as young as six months old
Philip Dormitzer says company opted for low-dose shot to avoid side effects
Concerns raised that vaccine sites and freight services will struggle during rollout of third jabs
Rise in hospitalisations among children forces districts to rethink return to in-person teaching
Judge approves bankruptcy plan for opioid maker in which family will pay $4.5bn
Delta surge prompts people to seek another Covid-19 vaccine dose
Drugmakers prepare for intense marketing competition to provide annual Covid jab
Dutch group’s market cap takes €10bn hit after detection of faulty component that patients say worsens their health
Data come amid debate over whether additional jabs are needed to increase protection
US president’s message comes after first full approval for a Covid-19 shot by the Food and Drug Administration
White House enlists TikTok influencers as less than half of youth are double-jabbed
International Edition
